Tocotrienol in the Management of Nonalcoholic Fatty Liver Disease: A Systematic Review

Tocotrienol in the Management of Nonalcoholic Fatty Liver Disease: A Systematic Review

The increasing burden of nonalcoholic fatty liver disease (NAFLD) requires innovative management strategies, but an effective pharmacological agent has yet to be found. Apart from weight loss and lifestyle adjustments, one isomer of the vitamin E family—alpha-tocopherol—is currently recommended for...

Full description

Bibliographic Details
Main Authors:	Kok-Yong Chin, Sophia Ogechi Ekeuku, Deborah Chia Hsin Chew, Anne Trias
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Nutrients
Subjects:	hepatitis metabolic disorders steatosis steatohepatitis vitamin E
Online Access:	https://www.mdpi.com/2072-6643/15/4/834

Similar Items

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Published: (2013-12-01)

Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease
by: Raptis DD, et al.
Published: (2023-01-01)

Treatment of nonalcoholic fatty liver disease
by: Paul Angulo, MD
Published: (2002-01-01)

The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease
by: Mary Barbara, et al.
Published: (2021-09-01)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
by: T. E. Promenasheva, et al.
Published: (2014-09-01)

The Association between Vitamin D and Nonalcoholic Fatty Liver Disease Assessed by Controlled Attenuation Parameter
by: Nam Ju Heo, et al.
Published: (2021-06-01)

Does vitamin E improve the outcomes of pediatric nonalcoholic fatty liver disease? A systematic review and meta-analysis
by: Ahmed A. Sarkhy, et al.
Published: (2014-01-01)

The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease
by: Ji-Yeon Seo, et al.
Published: (2021-10-01)

Prevalence of Metabolic-associated Fatty Liver Disease in Mexico and Development of a Screening Tool: The MAFLD-S Score
by: Jesus Ruiz-Manriquez, et al.
Published: (2022-01-01)

Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
by: Agostino Di Ciaula, et al.
Published: (2021-05-01)

Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis
by: Rasha AlShaalan, et al.
Published: (2015-01-01)

Biochemical assessment of metabolic associated fatty liver disease
by: Guerra-Ruiz Armando R., et al.
Published: (2021-03-01)

Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research
by: Clarissa Berardo, et al.
Published: (2020-12-01)

The genetics of nonalcoholic fatty liver disease
by: Christoph H. Österreicher;, et al.
Published: (2007-04-01)

Association of Hepatic Steatosis Index with Nonalcoholic Fatty Liver Disease Diagnosed by Non-Enhanced CT in a Screening Population
by: Jieun Chung, et al.
Published: (2021-11-01)

The Effects of Tocotrienol on Gut Microbiota: A Scoping Review
by: Aswini Kumareswaran, et al.
Published: (2023-09-01)

Prevalence and Clinical Characteristics of Nonalcoholic Liver Disease in Type 2 Diabetes Mellitus Patients: A Crosssectional Study
by: Lakshmi Ravansamudram Hariharan, et al.
Published: (2021-04-01)

Ultrasound Entropy Imaging of Nonalcoholic Fatty Liver Disease: Association with Metabolic Syndrome
by: Ying-Hsiu Lin, et al.
Published: (2018-11-01)

New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation
by: Antônio R. Andrade, et al.
Published: (2017-11-01)

How useful are monogenic rodent models for the study of human non-alcoholic fatty liver disease?
by: Jake Peter Mann, et al.
Published: (2016-11-01)

Noninvasive assessment of nonalcoholic fatty liver disease
by: Gajanan A Rodge, et al.
Published: (2021-01-01)

Prediction of course and progression of nonalcoholic fatty liver disease in patients with obesity and pathology of the biliary tract with the help of mathematical modeling.
by: A. Yu. Filippova, et al.
Published: (2017-12-01)

Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease
by: Ludovico Abenavoli, et al.
Published: (2021-02-01)

Integrated Multichip Analysis Identifies Potential Key Genes in the Pathogenesis of Nonalcoholic Steatohepatitis
by: Jianzhong Ye, et al.
Published: (2020-11-01)

Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
by: Wasitha P. D. W. Thilakarathna, et al.
Published: (2024-02-01)

Liver Ultrasound Elastography in Non-Alcoholic Fatty Liver Disease: A State-of-the-Art Summary
by: Rosanna Villani, et al.
Published: (2023-03-01)

Magnetic resonance‐based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Cyrielle Caussy, et al.
Published: (2020-10-01)

Metabolically associated fatty liver disease – a disease of the 21st century: A review
by: Igor V. Maev, et al.
Published: (2022-07-01)

SYSTEMATIC REVIEW WITH COMPARATIVE ANALYSIS OF RECOMMENDATIONS FOR THE DIAGNOSIS OF NONALCOHOLIC FATTY LIVER DISEASE
by: N.A. TOKTOGULOVA
Published: (2021-03-01)

Association Between Anxiety and Depression and Nonalcoholic Fatty Liver Disease
by: Ji Min Choi, et al.
Published: (2021-01-01)

Irinotecan-Induced Steatohepatitis: Current Insights
by: Jun Han, et al.
Published: (2021-10-01)

The Role of Bone Morphogenetic Protein 9 in Nonalcoholic Fatty Liver Disease in Mice
by: Qin-Juan Sun, et al.
Published: (2021-02-01)

Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
by: Yamei Duan, et al.
Published: (2022-05-01)

Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation Relevance
by: Madalina Andreea Robea, et al.
Published: (2023-09-01)

The Role of Tocotrienol in Arthritis Management—A Scoping Review of Literature
by: Hashwin Singh Tejpal Singh, et al.
Published: (2023-03-01)

Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease?
by: Maria Corina Plaz Torres, et al.
Published: (2020-11-01)

MXD3 Promotes Obesity and the Androgen Receptor Signaling Pathway in Gender-Disparity Hepatocarcinogenesis
by: Yi-Wen Tsai, et al.
Published: (2021-12-01)

Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic review
by: Huanqiu Wang, et al.
Published: (2022-08-01)

MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling
by: Chi-Yu Lai, et al.
Published: (2021-02-01)

Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review
by: Karima Begriche, et al.
Published: (2023-01-01)